Artificial intelligence in retinoblastoma and uveal melanoma – a narrative review
Artificial intelligence (AI) is reshaping diagnostic paradigms across oncology.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Beyond the Five-Year Milestone: Long‑term Survivorship of Melanoma Patients Treated Off‑Trial with anti‑PD‑1
- Uveal Melanoma – Trials in Disease – Overview of Information and Clinical Research
- Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis
- A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma
- Melanoma Research